<DOC>
	<DOCNO>NCT00848081</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy tadalafil give men currently take medication call alpha blocker treatment benign prostatic hyperplasia ( BPH ) symptom ( urinary frequency , urgency , feel bladder completely emptied urination ) .</brief_summary>
	<brief_title>A Study Tadalafil Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<mesh_term>Adrenergic alpha-Antagonists</mesh_term>
	<criteria>Stable alpha blocker therapy treatment BPH least 4 week prior start study . Have take follow treatment within indicated duration agree use time study : 1 . All Benign Prostatic Hyperplasia therapy ( include herbal preparation ) least 4 week prior receive study medication . 2 . Overactive Bladder therapy ( include antimuscarinics ) least 4 week prior receive study medication . 3 . Erectile Dysfunction therapy ( include herbal preparation ) least 4 week prior receive study medication . If take finasteride dutasteride , must take treatment least 6 month . Currently receive alphablocker therapy treatment hypertension . History symptom associate orthostasis , include recurrent episode dizziness , lightheadedness , loss consciousness , syncope . Treated nitrate cardiac condition . Have follow past 90 day : Heart attack , also know myocardial infarction ( MI ) ; Heart bypass surgery ( call coronary artery bypass graft surgery ) ; Had procedure open blood vessel heart know angioplasty stent placement ( percutaneous coronary intervention ) . Have problem kidney , liver , nervous system Have uncontrolled diabetes Have prostate cancer , treat cancer clinical evidence prostate cancer ( PSA great 10 ng/ml start study ) . Have stroke significant injury brain spinal cord .</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Prostate</keyword>
	<keyword>BPH</keyword>
	<keyword>Benign Prostatic Hyperplasia</keyword>
	<keyword>BPH-LUTS</keyword>
	<keyword>LUTS</keyword>
	<keyword>Phosphodiesterase Inhibitors</keyword>
	<keyword>tadalafil</keyword>
	<keyword>alpha blocker</keyword>
</DOC>